Mainz Biomed Reports Positive Topline Results from Pooled St

Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including previously unexamined and reported patients

Related Keywords

Berkeley , California , United States , Germany , Guido Baechler , Anne Hennecke Caroline Bergmann , Mainz Biomed , Mainz Biomed Colofuture Europe , Hershel Berry , Exchange Commission , Us Preventive Services Task , Centers For Disease , World Cancer Research Fund International , Mc Services , Company Colofuture , Blueprint Life Science Group , Chief Executive Officer , Disease Control , World Cancer Research Fund , Services Task Force , Polymerase Chain Reaction Based , Private Securities Litigation Reform Act ,